Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   
OVERLAP
14%

OVERLAP
BY WEIGHT
8

# OF OVERLAPPING
HOLDINGS
CANC
53
HOLDINGS
15%
ALSO IN XPH
XPH
47
HOLDINGS
17%
ALSO IN CANC
SECTOR DRIFT (CANC minus XPH)
OVERLAPPING HOLDINGS

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in CANC
Weight
in XPH
Overlap
ELI LILLY & CO 5.1% 3.0% 3.0%
JOHNSON & JOHNSON 3.2% 2.6% 2.6%
MERCK & CO. INC. 2.7% 2.6% 2.6%
BRISTOL-MYERS SQUIBB CO 3.4% 2.4% 2.4%
NUVATION BIO INC CLASS A 2.0% 3.4% 2.0%
CANC Overweight Relative to XPH
REVOLUTION MEDICINES, INC. 6.3%
BRIDGEBIO PHARMA, INC. 4.4%
ASTRAZENECA PLC 4.3%
NOVARTIS AG 4.1%
ROCHE HOLDINGS LTD-SPONS ADR 3.9%
COGENT BIOSCIENCES INC 3.9%
GENMAB A/S SPONSORED ADR 3.8%
NUVALENT, INC. CLASS A 3.3%
EXELIXIS INC 3.1%
ABBVIE INC 2.8%
CANC Underweight Relative to XPH
TERNS PHARMACEUTICALS, INC. -3.6%
TARSUS PHARMACEUTICALS, INC. -3.3%
CRINETICS PHARMACEUTICALS INC -3.2%
JAZZ PHARMACEUTICALS PLC -2.9%
WAVE LIFE SCIENCES LTD. -2.8%
CORCEPT THERAPEUTICS INC -2.7%
LIQUIDIA TECHNOLOGIES, INC. -2.7%
HARMONY BIOSCIENCES HOLDINGS, INC. -2.7%
AXSOME THERAPEUTICS, INC. -2.6%
ELANCO ANIMAL HEALTH, INC. -2.6%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY